Improving Outcomes in Systemic Lupus Erythematosus and Lupus Nephritis

This program aims to help healthcare providers who work with SLE patients improve patient outcomes through evidenced based management strategies and emerging therapies. Information in this program includes an emphasis on lupus nephritis.

Supported by an educational grant from Glaxo SmithKline LLC

Developed in Partnership with the Lupus Research Alliance

Target Audience

  • Pharmacists
  • Physicians
  • Family Physicians
  • Physician Assistants
  • Nurse Practitioners
  • Nurses 

Learning Objectives

Upon completion of this activity you will be better able to:

  • Describe the pathogenesis of SLE and its kidney-related manifestations, including nephrotic syndrome
  • Identify evidence-based strategies to diagnose SLE and assess disease activity and damage
  • Discuss management strategies in patients with SLE using a case-based approach to improve outcomes
Additional information
AttachmentSize
References.pdf154.07 KB
Course summary
Available credit: 
  • 1.00 AAFP Prescribed Credits
  • 0.25 AANP and ANCC Pharmacology
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Nurse Contact Hours
  • 0.25 ANCC Pharmacology
  • 1.00 Attendance
  • 1.00 Category I Credit for Physician Assistants
  • 1.50 ABIM MOC
Course opens: 
09/18/2019
Course expires: 
09/18/2020
Cost:
$0.00
Rating: 
0

Mary Crow, MD
Physician-in-Chief
Hospital for Special Surgery
New York, NY
Disclosure: Consultant: Bristol Myers Squib, Aztra Zeneca, Lilly, Neovacs, Janssen and Kirin

Brad Rovin, MD
Professor of Medicine and Pathology
Ohio State University
Columbus, OH
Disclosure: Advisory Board: Genentech, Aurinia, BMS, Janssen, Madimune, RILITE; Research: EMD Serono

Ellen Ginzler, MD, MPH
Chief of Rhumatology
State University of New York
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Planning Committee Disclosures

Monica Richey, MSN, ANP-bc/GNP
Nurse Practitioner
Northwell Health
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Martin Quan, MD
Professor of Clinical Family Medicine
David Geffen School of Medicine at UCLA
Sherwood Forest, CA
Disclosure: Has no financial relationships with commercial interest(s).

Deborah Brommage, MS, RDN, CSR, CDN
Program Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Professional Education Manager
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).
 

DECLARATION OF DISCLOSURE:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

UNLABELED/INVESTIGATIONAL USE:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

ACCREDITATION/DESIGNATION OF CREDIT STATEMENTS:

In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician

The National Kidney Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurse Practitioner and Nurse

Awarded 1.0 contact hours of continuing nursing education (includes 0.25 contact hours in the area of pharmacology).

Pharmacist

This knowledge-based enduring activity has been assigned Universal Activity Number JA0004461-0000-19-018-H01-P, for 1.0 contact hours (0.10 CEUs). To receive credit, learners must read the activity overview, learning objectives and faculty disclosures, complete the pre-test, review the content, complete the post-test with a minimum score of 70% (post-test may be taken up to 3 times) and electronic activity evaluation. An NABP eProfile ID and date of birth in MMDD format are prerequisites for receiving continuing pharmacy education credits. All credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity. Please contact cmeinfo@kidney.org if you do not see activity information listed in your profile within 30 days.  For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.

Physician Assistant 

The National Kidney Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. AAPA accepts Category I credit from AOACCME, prescribed credit from AAFP, and AMA Category I Credit(s)TM from organizations accredited by ACCME.  

Physician assistants may receive a maximum of 1.0 hours of Category I credit for completing this program.
 

Available Credit

  • 1.00 AAFP Prescribed Credits
  • 0.25 AANP and ANCC Pharmacology
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Nurse Contact Hours
  • 0.25 ANCC Pharmacology
  • 1.00 Attendance
  • 1.00 Category I Credit for Physician Assistants
  • 1.50 ABIM MOC

Accreditation Period

Course opens: 
09/18/2019
Course expires: 
09/18/2020

Price

Cost:
$0.00
Please login or register for a PERC account to take this course.
DISCLAIMER:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.